LP-128 Relative efficacy and safety of tacrolimus, mycophenolate mofetil, and azathioprine as maintenance therapies for lupus nephritis: a network meta-analysis

LP-128 Relative efficacy and safety of tacrolimus, mycophenolate mofetil, and azathioprine as maintenance therapies for lupus nephritis: a network meta-analysis

Bibliographic Details
Main Authors:	Young Ho Lee, Gwan Gyu Song
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-07-01
Series:	Lupus Science and Medicine

Similar Items

Addition of cyclosporine/tacrolimus for pediatric relapsed lupus nephritis during mycophenolate mofetil maintenance therapy
by: Youying Mao, et al.
Published: (2019-01-01)

Mycophenolate mofetil in the treatment of lupus nephritis
by: Patrick FK Yong, et al.
Published: (2008-06-01)

Comparison between Mycophenolate Mofetil and Azathioprine for Preventing Renal Relapse in Lupus Nephritis: An Evidence-based Case Report
by: Bambang Setiyohadi, et al.
Published: (2018-12-01)

Comparative Efficacy and Safety of Mycophenolate Mofetil and Azathioprine in Combination with Corticosteroids in the Treatment of Lymphocytic Myocarditis
by: Olga Blagova, et al.
Published: (2023-07-01)

Comparative efficacy and safety of mycophenolate mofetil and azathioprine in combination with corticosteroids in the treatment of lymphocytic myocarditis
by: R. S. Rud, et al.
Published: (2021-12-01)

Successful Treatment of Mucocutaneous Lupus Erythematosus in a Dog with Prednisolone, Mycophenolate Mofetil and Tacrolimus
by: Jae-Eun Hyun, et al.
Published: (2021-04-01)

The effect of mycophenolate mofetil on podocytes in nephrotoxic serum nephritis
by: A. Hackl, et al.
Published: (2023-08-01)

Comparison of the Effectiveness and Safety of Mycophenolate Mofetil and Cyclophosphamide in Lupus Nephritis: Evidence from a Real-World Study
by: Xiaohui Zhang, et al.
Published: (2023-07-01)

Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis
by: Moore, R, et al.
Published: (2006)

Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation
by: Hyeyoung Kim, et al.
Published: (2014-09-01)

LP-127 Tacrolimus is effective treatment in patients with refractory lupus nephritis
by: Chang-Hee Suh, et al.
Published: (2023-07-01)

Long-term results of mycophenolate mofetil vs. azathioprine use in individuals with autoimmune hepatitis
by: George N. Dalekos, et al.
Published: (2022-12-01)

Treatment of severe henoch-schonlein purpura nephritis with mycophenolate mofetil
by: Ahmad Ali Nikibakhsh, et al.
Published: (2014-01-01)

Sex-Specific Responses to Tacrolimus and Mycophenolate Mofetil in Spontaneously Hypertensive Rats
by: Rodrigo Oscar Marañón, et al.
Published: (2023-11-01)

Analysis of the Clinical Effects of the Combination of Mycophenolate Mofetil with Either Tacrolimus or Cyclophosphamide
by: Xuebing Zhang, et al.
Published: (2020-11-01)

Mycophenolate mofetil or cyclophosphamide in indian patients with lupus nephritis: Which is better? A single-center experience
by: Satish Mendonca, et al.
Published: (2017-01-01)

Effect of conversion from azathioprine to mycophenolate mofetil on renal function in stable kidney transplant recipients
by: Mehmet Usta, et al.
Published: (2019-10-01)

Utilization of Mycophenolic Acid, Azathioprine, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus: Multinational Study
by: Majda Sahman, et al.
Published: (2021-03-01)

Population pharmacokinetics and limited sampling strategy for therapeutic drug monitoring of mycophenolate mofetil in Japanese patients with lupus nephritis
by: Tomoko Mizaki, et al.
Published: (2023-01-01)

Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial
by: Romée J. A. L. M. Snijders, et al.
Published: (2022-12-01)

Long-Term Results of Triple Immunosuppression With Tacrolimus Added to Mycophenolate and Corticosteroids in the Treatment of Lupus Nephritis
by: Desmond Y.H. Yap, et al.
Published: (2022-03-01)

Safety of Tacrolimus Monotherapy within 12 Months after Liver Transplantation in the Era of Reduced Tacrolimus and Mycophenolate Mofetil: National Registry Study
by: Deok Gie Kim, et al.
Published: (2022-05-01)

Increased Exposure of Tacrolimus by Co-administered Mycophenolate Mofetil: Population Pharmacokinetic Analysis in Healthy Volunteers
by: Jae Hyun Kim, et al.
Published: (2018-01-01)

A Comparison of Azathioprine and Mycophenolate Mofetil as Adjuvant Drugs in Patients with Pemphigus: A Retrospective Cohort Study
by: Siriorn Sukanjanapong, et al.
Published: (2019-12-01)

Mycophenolate mofetil and tacrolimus versus tacrolimus alone for the treatment of idiopathic membranous glomerulonephritis: a randomised controlled trial
by: Aikaterini Nikolopoulou, et al.
Published: (2019-09-01)

Belimumab and low-doses of mycophenolate mofetil as induction therapy of class IV lupus nephritis: case series and literature review
by: Domenico Paolo Emanuele Margiotta, et al.
Published: (2018-03-01)

Mycophenolate mofetil and atherosclerosis
by: Z S Alekberova, et al.
Published: (2009-10-01)

Protective effect of melatonin and mycophenolate mofetil against nephrotoxicity induced by tacrolimus in wistar rats
by: Suleyman KOC, et al.
Published: (2021-11-01)

Mycophenolate mofetil enhances the negative effects of sirolimus and tacrolimus on rat kidney cell metabolism.
by: Jelena Klawitter, et al.
Published: (2014-01-01)

Efficacy and safety of a conversion from the original tacrolimus and mycophenolate mofetil to the generics Tacpan® and Mowel® after liver transplantation
by: Vollmar J, et al.
Published: (2015-11-01)

Comparative efficacy and safety of mizoribine and mycophenolate mofetil for treating systemic lupus erythematosus: a retrospective cohort study
by: Masahiro Ayano, et al.
Published: (2022-05-01)

Uso de micofenolato mofetil em pacientes com lúpus eritematoso sistêmico juvenil e nefrite refratária Use of mycophenolate mofetil in patients with juvenile systemic lupus erythematosus and refractory nephritis
by: Ricardo Maisse Suehiro, et al.
Published: (2004-10-01)

Low dose mycophenolate mofetil versus cyclophosphamide in the induction therapy of lupus nephritis in Nepalese population: a randomized control trial
by: Arun Sedhain, et al.
Published: (2018-07-01)

Steroid Refractory Immune Checkpoint Induced Acute Interstitial Nephritis Salvaged by Mycophenolate Mofetil
by: Prashanth Moku, et al.
Published: (2023-04-01)

Mycophenolate mofetil for the treatment of Henoch-Schönlein purpura nephritis; current knowledge and new concepts
by: Azar Nickavar, et al.
Published: (2017-07-01)

Role of tacrolimus combination therapy with mycophenolate mofetil in the prevention of organ rejection in kidney transplant patients
by: P Dalal, et al.
Published: (2010-08-01)

Qualitative analysis of the deposit of collagen in bladder suture of rats treated with tacrolimus combined with mycophenolate-mofetil
by: Gustavo Marquesine Paul, et al.
Published: (2014-04-01)

Mycophenolate Mofetil (MMF) for the treatment of juvenile onset systemic lupus erythematosus
by: Falcini FF, et al.
Published: (2008-09-01)

The first investigation on differences in the effectiveness of mycophenolate mofetil and azathioprine antimetabolites determined in Polish patients treated for non-infectious uveitis
by: Maja Waszczyk-Łączak, et al.
Published: (2020-12-01)

First Results From a Propensity Matching Trial of Mycophenolate Mofetil vs. Azathioprine in Treatment-Naive AIH Patients
by: George N. Dalekos, et al.
Published: (2022-01-01)